Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells
暂无分享,去创建一个
H. Abboud | D. Féliers | B. Kasinath | Y. Gorin | G. Ghosh-Choudhury | Meenalakshmi M. Mariappan | Doug‐Yoon Lee | H. Lee
[1] N. Tamimi,et al. Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. , 2016, Journal of the American Society of Nephrology : JASN.
[2] Jessica Pham,et al. Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.
[3] H. Schmidt,et al. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy , 2016, Diabetologia.
[4] H. Abboud,et al. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. , 2015, American journal of physiology. Renal physiology.
[5] D. Féliers,et al. Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes* , 2015, The Journal of Biological Chemistry.
[6] S. Tyagi,et al. Hydrogen Sulfide Epigenetically Attenuates Homocysteine‐Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells , 2015, Journal of cellular physiology.
[7] Sa Shi,et al. Sodium hydrosulfide attenuates hyperhomocysteinemia rat myocardial injury through cardiac mitochondrial protection , 2014, Molecular and Cellular Biochemistry.
[8] H. Schmidt,et al. Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy , 2014, Physiological reports.
[9] Huan Wang,et al. HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury , 2014, PloS one.
[10] Xiaoping Zhou,et al. Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model , 2014, The Journal of Biological Chemistry.
[11] Qian Huang,et al. Hydrogen Sulfide Releasing Aspirin, ACS14, Attenuates High Glucose-Induced Increased Methylglyoxal and Oxidative Stress in Cultured Vascular Smooth Muscle Cells , 2014, PloS one.
[12] R. Touyz,et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.
[13] Rui Wang. Gasotransmitters: growing pains and joys. , 2014, Trends in biochemical sciences.
[14] G. Tonolo,et al. Tubulointerstitial disease in diabetic nephropathy , 2014, International journal of nephrology and renovascular disease.
[15] G. Dusting,et al. NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses , 2014, Redox biology.
[16] K. Block,et al. Nox as a target for diabetic complications. , 2013, Clinical science.
[17] A. Eid,et al. Nox4 NADPH Oxidase Mediates Peroxynitrite-dependent Uncoupling of Endothelial Nitric-oxide Synthase and Fibronectin Expression in Response to Angiotensin II , 2013, The Journal of Biological Chemistry.
[18] K. Block,et al. Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? , 2013, Free radical biology & medicine.
[19] A. Eid,et al. Sestrin 2 and AMPK Connect Hyperglycemia to Nox4-Dependent Endothelial Nitric Oxide Synthase Uncoupling and Matrix Protein Expression , 2013, Molecular and Cellular Biology.
[20] L. Rosivall,et al. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] J. Kim,et al. AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. , 2013, American journal of physiology. Renal physiology.
[22] R. Touyz,et al. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. , 2013, Clinical science.
[23] H. Abboud,et al. Transforming Growth Factor β Integrates Smad 3 to Mechanistic Target of Rapamycin Complexes to Arrest Deptor Abundance for Glomerular Mesangial Cell Hypertrophy* , 2013, The Journal of Biological Chemistry.
[24] Eva Dizin,et al. NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. , 2012, Journal of the American Society of Nephrology : JASN.
[25] Oliver Jung,et al. Role of Nox4 in murine models of kidney disease. , 2012, Free radical biology & medicine.
[26] Y. Yuzawa,et al. Distribution of hydrogen sulfide (H2S)-producing enzymes and the roles of the H2S donor sodium hydrosulfide in diabetic nephropathy , 2012, Clinical and Experimental Nephrology.
[27] Rui Wang. Shared signaling pathways among gasotransmitters , 2012, Proceedings of the National Academy of Sciences.
[28] A. Papapetropoulos,et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation , 2012, Proceedings of the National Academy of Sciences.
[29] M. A. Moseley,et al. Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation. , 2012, Free radical biology & medicine.
[30] H. Abboud,et al. Hydrogen Sulfide Inhibits High Glucose-induced Matrix Protein Synthesis by Activating AMP-activated Protein Kinase in Renal Epithelial Cells*♦ , 2011, The Journal of Biological Chemistry.
[31] Yunchao Su,et al. Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. , 2011, Antioxidants & redox signaling.
[32] A. Papapetropoulos,et al. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function , 2011, Proceedings of the National Academy of Sciences.
[33] Yu Huang,et al. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] H. Abboud,et al. AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes* , 2010, The Journal of Biological Chemistry.
[35] P. Asfar,et al. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats , 2010, Critical care.
[36] T. Murphy,et al. PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[37] S. Jha,et al. Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in Mice , 2010, Circulation.
[38] T. Murphy,et al. PPARγ regulates hypoxia‐induced Nox4 expression in human pulmonary artery smooth muscle cells through NF‐κB , 2010 .
[39] A. Abbate,et al. Phosphodiesterase-5 Inhibitor, Tadalafil, Protects Against Myocardial Ischemia/Reperfusion Through Protein-Kinase G–Dependent Generation of Hydrogen Sulfide , 2009, Circulation.
[40] S. Jha,et al. Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling , 2009, Circulation research.
[41] M. Carraway,et al. Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1 , 2008, Circulation research.
[42] S. Snyder,et al. H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase , 2008, Science.
[43] J. Moon,et al. Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats , 2008, American Journal of Nephrology.
[44] B. Falkner,et al. Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.
[45] G. Dusting,et al. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. , 2007, Cardiovascular research.
[46] M. Gannon,et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. , 2007, The American journal of pathology.
[47] B. Viollet,et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. , 2007, American journal of physiology. Renal physiology.
[48] R. Harris,et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. , 2006, Journal of the American Society of Nephrology : JASN.
[49] H. Abboud,et al. Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney* , 2005, Journal of Biological Chemistry.
[50] B. Halliwell,et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite ‘scavenger’? , 2004, Journal of neurochemistry.
[51] Samantha A. Tavener,et al. Complexity of Inducible Nitric Oxide Synthase: Cellular Source Determines Benefit Versus Toxicity , 2003, Circulation.
[52] Paul L Huang,et al. Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse Kidney* , 2003, Journal of Biological Chemistry.
[53] J. Sanes,et al. Regulation of renal laminin in mice with type II diabetes. , 1999, Journal of the American Society of Nephrology : JASN.
[54] H. Trachtman,et al. Chronic diabetic nephropathy: role of inducible nitric oxide synthase , 2002, Pediatric Nephrology.
[55] Y. Goto,et al. The FASEB Journal express article 10.1096/fj.04-1815fje. Published online May 20, 2004. Hydrogen sulfide protects neurons from oxidative stress , 2022 .